-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M9/ULXU+TU5tSX7LVfSsJskPgyDeXSWa8ye88SBO83IGXtdYKdfsy/NNYZHUNHUY RuQLprhtpfxiLLuou1iv/g== 0001072613-04-000375.txt : 20040217 0001072613-04-000375.hdr.sgml : 20040216 20040217172048 ACCESSION NUMBER: 0001072613-04-000375 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040217 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ABELE JOHN E CENTRAL INDEX KEY: 0000901430 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: 480 PLEASANT ST CITY: WATERTOWN STATE: MA ZIP: 02172 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43484 FILM NUMBER: 04610307 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 SC 13G/A 1 abele2003_12497d.txt SCH. 13G/A - JOHN ABELE - DEC. 2003 ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13D-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(B), (C), AND (D) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(B) (AMENDMENT NO. 11)(1) BOSTON SCIENTIFIC CORPORATION - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.01 par value per share - -------------------------------------------------------------------------------- (Title or Class of Securities) 101137 10 7 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2003 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) __________________________________ (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ================================================================================ ===================== =========== CUSIP NO. 101137 10 7 13G PAGE 2 OF 5 ===================== =========== ================================================================================ 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) John E. Abele - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] Not applicable. (b) [_] - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION The United States of America - ------- ------------------------------------------------------------------------ 5 SOLE VOTING POWER 54,444,500 (See Item 4(a)) NUMBER OF ------- ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,179,838 EACH ------- ----------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 54,444,500 (See Item 4(a)) ------- ----------------------------------------------------- 8 SHARED DISPOSITIVE POWER 1,179,838 - ------- ------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 55,624,338 - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [X] - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.7% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN ================================================================================ ===================== =========== CUSIP NO. 101137 10 7 13G PAGE 3 OF 5 ===================== =========== ITEM 1(A). NAME OF ISSUER: Boston Scientific Corporation, a Delaware corporation ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: One Boston Scientific Place Natick, MA 01760 ITEM 2(A). NAME OF PERSON FILING: John E. Abele (the "Reporting Person") ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: c/o Boston Scientific Corporation One Boston Scientific Place Natick, MA 01760 ITEM 2(C). CITIZENSHIP: The United States of America ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock, $0.01 par value per share ITEM 2(E). CUSIP NUMBER: 101137 10 7 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A: Not applicable. ITEM 4. OWNERSHIP: (a) Amount beneficially owned: The Reporting Person owns beneficially a total of 55,624,338(2) shares. (b) Percent of class: 6.7% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 54,444,500 (ii) Shared power to vote or to direct the vote: 1,179,838 (iii) Sole power to dispose or to direct the disposition of: 54,444,500 (iv) Shared power to dispose or to direct the disposition of: 1,179,838 ===================== =========== CUSIP NO. 101137 10 7 13G PAGE 4 OF 5 ===================== =========== ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10. CERTIFICATIONS: Not applicable. _______________________ (2) Includes 818,400 shares owned by a charitable trust of which the Reporting Person is a trustee and shares investment and ownership control and 361,438 shares owned by a trust of which the Reporting Person is a trustee and shares investment and ownership control. Also includes 181,000 shares subject to exercisable options granted to the Reporting Person. Does not include 400,000 shares owned by the Reporting Person's wife. In accordance with Rule 13d-4, the Reporting Person disclaims beneficial ownership of these 400,000 shares. ===================== =========== CUSIP NO. 101137 10 7 13G PAGE 5 OF 5 ===================== =========== SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 17, 2004 - ----------------------- (Date) /s/ John E. Abele -------------------------- John E. Abele -----END PRIVACY-ENHANCED MESSAGE-----